Publication | Closed Access

Apremilast and narrowband ultraviolet B combination therapy suppresses Th17 axis and promotes melanogenesis in vitiligo skin: a randomized, split-body, pilot study in skin types IV–VI

Cutaneous BiologyPhotocarcinogenesisImmunologySkin Types Iv–viPathologyTh17 AxisDermatologyExperimental DermatologyVitiligo SkinMedicineMolecular MedicineSkin Cancer